| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.11. | BioNexus Gene Lab Corp.: BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific | 2 | GlobeNewswire (USA) | ||
| 30.10. | BioNexus Gene Lab Corp.: BioNexus Launches New Corporate Website with Expanded Business and Investor Resources | 1 | GlobeNewswire (USA) | ||
| BIONEXUS GENE LAB Aktie jetzt für 0€ handeln | |||||
| 07.10. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 05.10. | Ruanyun Edai Technology Inc.: RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab | 1 | GlobeNewswire (USA) | ||
| 14.08. | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 28.07. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 28.07. | BioNexus Gene Lab Corp.: BioNexus Advances VitaGuard Southeast Asia Rollout Following China Working Visit | 1 | GlobeNewswire (USA) | ||
| 03.07. | Eastwood Bio-Medical Canada Inc: Eastwood signs research agreement with BioNexus | 1 | Stockwatch | ||
| 05.06. | BioNexus Gene Lab Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 29.05. | BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Cooperation to Move Beyond Trade into Co-Development | 1 | GlobeNewswire (USA) | ||
| 11.03. | BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard MRD Platform | 958 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, March 11, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) today announced that, in connection with its Fidelion Diagnostics Pte. Ltd ("Fidelion") transaction... ► Artikel lesen | |
| 23.02. | BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman | 345 | GlobeNewswire (Europe) | Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp.... ► Artikel lesen | |
| 02.12.25 | BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization | 284 | GlobeNewswire (Europe) | SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC" or the "Company"), an emerging provider of precision oncology diagnostics with expanding operations across Southeast... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DRAEGERWERK | 116,80 | -1,85 % | Ihre wichtigsten Termine: Heute im Fokus: Target, Drägerwerk, Oracle, TJX, Lowe's, Bullish und Novartis | © Foto: Eibner-Pressefoto/Ardan Fuessman - Eibner-PressefotoGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,600 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program | ||
| FRESENIUS MEDICAL CARE | 37,760 | -2,07 % | Fresenius platziert FMC-Aktien zu je 39 Euro - Bruttoerlös 524 Mio EUR | DJ Fresenius platziert FMC-Aktien zu je 39 Euro - Bruttoerlös 524 Mio EUR
DOW JONES--Fresenius hat seine Beteiligung an Fresenius Medical Care (FMC) weiter verringert. Wie der im DAX notierte Gesundheitskonzern... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,890 | +0,11 % | Aktie zieht an!: Siemens liefert und legt nach, die Strategie überzeugt wirft Fragen auf | © Foto: Joko - JokoSiemens meldet Rekordzahlen und hebt die Mittelfristziele an. Anleger bleiben trotzdem skeptisch, denn die neue Konzernstrategie gilt vielen noch als zu unscharf Enthaltene Werte:... ► Artikel lesen | |
| BILLIONTOONE | 91,50 | -6,15 % | BillionToOne weist Vorwürfe aus Leerverkäufer-Bericht zurück | ||
| BRIGHTSPRING HEALTH SERVICES | 68,35 | 0,00 % | BMO raises BrightSpring Health stock price target on LDD momentum | ||
| GENEDX | 52,19 | 0,00 % | GeneDx Taps Everett Cunningham as CEO | ||
| LIFESTANCE HEALTH GROUP | 13,785 | +0,11 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 6,735 | 0,00 % | Alignment Healthcare falls 9% amid weakness in Medicare Advantage stocks | ||
| FRESENIUS | 52,74 | -1,29 % | EQS-News: Fresenius SE & Co. KGaA: Moody's hebt Kreditausblick für Fresenius von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
Moody's hebt Kreditausblick für Fresenius von stabil auf positiv an (News mit Zusatzmaterial)
19.11.2026 / 13:45... ► Artikel lesen | |
| HEARTFLOW | 45,905 | +0,03 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| ARDENT HEALTH | 14,370 | -0,14 % | Ardent Health Stock Falls 20% After Secondary Offering Price Set | ||
| PROCEPT BIOROBOTICS | 25,190 | 0,00 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| AVEANNA HEALTHCARE | 10,840 | 0,00 % | RBC Capital reiterates Aveanna Healthcare stock rating at Outperform | ||
| AGILON HEALTH | 90,61 | 0,00 % | Bernstein raises agilon health stock price target on higher EBITDA |